Mayo Clinic trial to use stem cells to treat infant heart defects

The Mayo Clinic has received federal approval for a stem cell trial that will use babies' own umbilical cords to treat heart defects such as hypoplastic left heart syndrome. The trial, considered as the first of its kind, will commence upon enrollment of 10 eligible patients. Dr. Harold Burkhart, who will head the surgeries in the study, said that at the Mayo Clinic, about 9 out of 10 survive the procedures.

View Full Article in:

Star Tribune (Minneapolis-St. Paul, Minn.) · KTTC-TV (Minn)

Published in Briefs:

SmartBrief Job Listings for Education

Job Title Company Location
K-12 Teachers Needed at Int’l Schools
The International Educator
Multiple Locations
Instructional Designer, ESL
Imagine Learning, Inc.
Provo, UT
Sr. Product Manager - Professional Development
NWEA
Nationwide, SL_Nationwide
Sr. Product Manager - Formative Assessment Product Line
NWEA
Nationwide, SL_Nationwide
Account Executive
NWEA
Multiple Locations, SL_Multiple Locations